Chuo-ku, Japan

Masatsugu Noguchi


Average Co-Inventor Count = 11.5

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Kawasaki, JP (2012)
  • Chuo-ku, JP (2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Masatsugu Noguchi: A Pioneer in Pharmaceutical Patents

Introduction

Masatsugu Noguchi, a notable inventor based in Chuo-ku, Japan, has made significant contributions to the field of pharmaceuticals. With two patents to his name, his work primarily focuses on developing compounds that are essential in treating various medical conditions.

Latest Patents

Masatsugu Noguchi's latest patents include groundbreaking inventions such as "Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity." This patent describes a compound with α4 integrin inhibitory action, which is represented by a sulfonamide derivative, crucial for medical applications. Another prominent patent is focused on "Pyrazolo-pyrimidine compounds," aimed at providing a pharmaceutical composition for preventing or treating diseases associated with excess IL-12/IL-23 production.

Career Highlights

Throughout his career, Noguchi has worked with prominent companies, including Ea Pharma Co., Ltd. and Ajinomoto Co., Ltd. His tenure in these organizations has allowed him to innovate and patent compounds that address critical medical needs.

Collaborations

Masatsugu Noguchi has collaborated with esteemed colleagues, including Nobuhiko Hayakawa and Misato Noguchi. Their teamwork has significantly advanced their research and contributed to the successful development of new pharmaceutical compounds.

Conclusion

Masatsugu Noguchi stands out as a dedicated inventor whose patents continue to impact the pharmaceutical industry significantly. His ongoing work demonstrates the importance of innovation in developing solutions for complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…